ARCT: Arcturus Therapeutics Holdings Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 432.59
Enterprise Value ($M) 195.56
Book Value ($M) 240.98
Book Value / Share 8.90
Price / Book 1.80
NCAV ($M) 202.89
NCAV / Share 7.49
Price / NCAV 2.13

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.19
Return on Equity (ROE) -0.29

Liquidity (mrq)
Quick Ratio 4.67
Current Ratio 4.67

Balance Sheet (mrq) ($M)
Current Assets 305.98
Assets 344.07
Liabilities 103.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 152.31
Operating Income -95.67
Net Income -80.94
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -59.75
Cash from Investing -0.65
Cash from Financing 5.42

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-05 13G State Street Corp 4.90 -18.62
11-08 13G Nikko Asset Management Americas, Inc. 8.56 75.31
11-05 13G Sumitomo Mitsui Trust Holdings, Inc. 8.56 75.31
04-05 13G/A BlackRock, Inc. 10.20 14.37
2024-02-13 13G/A Vanguard Group Inc 5.46 0.55

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 197,808 699,940 28.26
2025-03-06 51,323 259,071 19.81
2025-03-05 77,500 264,002 29.36
2025-03-04 78,443 390,604 20.08
2025-03-03 63,391 294,224 21.55

(click for more detail)

Similar Companies
APGE – Apogee Therapeutics, Inc. APLT – Applied Therapeutics, Inc.
AQST – Aquestive Therapeutics, Inc. ARDX – Ardelyx, Inc.
ATAI – Atai Life Sciences N.V.


Financial data and stock pages provided by
Fintel.io